Results 91 to 100 of about 419,320 (165)

Gaps and paths forward in cancer pharmacology and translational research. [PDF]

Front Pharmacol
Hughes EA, Davenport LL, Zdyrski C, Pawlak A, Mochel JP, Douglass EF.   +5 more
europepmc   +1 more source

Dose-Concentration Relationship and Clinical Outcomes of Duloxetine in Generalized Anxiety Disorder. [PDF]

J Clin Med
Baykan O, Altunoz S, Yilmaz Uyanik D, Baykan H.   +3 more
europepmc   +1 more source

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer. [PDF]

J Clin Pharmacol
Tang Z, Lim K, Jiang Y, Denduluri N, Rokutanda N, Pan Y, Hong Y, Ren S, Vajjah P, Zhou D.   +9 more
europepmc   +1 more source

The Role of Pharmacogenetics in the Effectiveness of Rheumatoid Arthritis Treatment with Leflunomide. [PDF]

Genes (Basel)
Plewa P, Jędrasiak A, Jerzyńska O, Dach A, Domańska M, Pawlik A.   +5 more
europepmc   +1 more source

Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention model. [PDF]

J Antimicrob Chemother
Collins LB, Le A, Nicol MR.
europepmc   +1 more source

Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event Data. [PDF]

CPT Pharmacometrics Syst Pharmacol
Goulooze SC, Snelder N, Eissing T, Garmann D.   +3 more
europepmc   +1 more source

Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study. [PDF]

Clin Transl Sci
Pan S, Tsakok T, Wei R, Dand N, Loeff FC, Bloem K, de Vries A, Baudry D, Duckworth M, Pushpa-Rajah A, Russell A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Mahil SK, Standing JF, Smith CH, BADBIR Study Group, BSTOP Study Group and the PSORT Consortium.   +26 more
europepmc   +1 more source

Plasma 5-Fluorouracil Exposure, Clinical Outcomes, and Therapeutic Drug Monitoring in Advanced Colorectal Cancer. [PDF]

Cancers (Basel)
Sakuyama N, Nagayasu K, Abe Y, Ochiai T, Shibasaki F.   +4 more
europepmc   +1 more source

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century? [PDF]

Pharmacotherapy
Ryder JH, Sunagawa SW, Rhodes NJ, Van Schooneveld TC, Tigh JE, Avedissian SN, Cortes-Penfield N.   +6 more
europepmc   +1 more source